Somatic mutation of Ig variable regions occurs prominently in germinal centers, but it has been debated whether the mutation process initiates in germinal centers or is activated before germinal center entry of B cells. We have analyzed for the presence of somatic mutation in Ig gene rearrangements of the nonpolymorphic human VH6 gene in the X-linked HyperIgM syndrome, which is associated with defective CD40 ligand expression and absence of germinal centers and generation of memory B lymphocytes. IgM and rare IgG VH6 productive rearrangements were isolated from PBL of patients with X-linked HyperIgM syndrome. Although the majority of both the IgM and IgG VH6 rearrangements had a germline VH6 sequence, 7 of 102 VH6 IgM and 1 of 6 IgG rearrangements had a mutated VH6 gene. The mutation frequency (mutations/bp) was 1.4% with a range of 2-9 mutations per clone, a mutation frequency lower, however, than that observed in IgM (3.2%) and IgG (5.4%) VH6 rearrangements of normal individuals. These results suggest that somatic mutation may be initiated in a CD40 ligand-independent pathway before entry of B cells into germinal centers, but fails to achieve the high mutation frequency observed in the presence of germinal centers. (J. Clin. Invest. 1995. 95:1389-1393 
Introduction
B lymphocytes undergo a process of somatic hypermutation after in vivo activation by antigen and T cells that introduces point mutations into the rearranged immunoglobulin variable region (V)' (1) (2) (3) . Mutations that increase affinity of the surface Ig of the B cell are then selected into the repertoire by antigen and T cells. The signals that activate this mutation process are unknown. Somatic mutation of Ig V regions is most prominent in B cells in germinal centers of lymphoid tissue (4) (5) (6) (7) . It is unclear, however, whether the mutation process is activated initially in germinal centers or begins with B cell activation in extrafollicular sites in lymphoid organs and then increases to a high rate when these activated B cells enter into germinal centers. Suggestive of the former possibility is the finding that when the sequences of Ig V regions of B cells in extrafollicular sites and germinal centers are compared, somatic mutation is found only in B cells isolated from germinal centers (8, 9) . Also, somatic mutation of V genes is not invariably observed in B cells that initially populate germinal centers early after immunization (9, 10) . Altematively, some investigators have suggested that mutations are introduced after immunization into rearranged Ig V region genes before the time of development of germinal centers (6, 11 ) .
Germinal center formation fails to occur in mice in the absence of normal CD40-CD40 ligand (CD40L) interactions as found in CD40 (12, 13) and CD40L (14) gene-targeted deficient mice. The CD40 and CD40L gene-deficient mice fail to generate IgG antibody responses to thymus-dependent (TD) antigens and memory B cells, but do develop normal levels of serum IgM, normal IgM, and IgG antibody responses to thymusindependent antigens, and IgM antibody responses to some, but not all, TD antigens (12) (13) (14) . Affinity maturation of antibody or generation of somatic mutation in rearranged Ig V regions in these gene-deficient mice has not been described.
The human X-linked HyperIgM syndrome (HIGMX-1) is associated with abnormal CD40L function (15) (16) (17) (18) . Affected boys with this disorder suffer from recurrent pyogenic infections, autoimmune diseases, and lymphoproliferative disorders. They have normal to elevated levels of IgM, but decreased to absent levels of IgG, IgA, and IgE ( 19). Circulating B cells in patients with HIGMX-1 are normal in number but are usually surface IgM positive with absence of cell surface IgG or IgA. Patients with HIGMX-1 fail to generate germinal centers, IgG antibody, and normal secondary antibody responses, but they do generate IgM antibody, even after immunization with TD antigens ( 19, 20) . CD40-CD40L interactions are important in B cell proliferation, B cell isotype switching with costimulation with cytokines, and, possibly, in prevention of B cell apoptosis ( 15-18, 21, 22) . Signaling of B cells through CD40 interactions has been suggested to occur in extrafollicular sites in lymphoid organs in the initial activation of B cells as well as in germinal centers in the selection of memory B cells (17, 18, 23, 24) and, therefore, the immunologic defects in these patients can be explained by an abnormality of CD40 signaling at these sites.
It is not known whether the immunoglobulin or IgM antibody of patients with HIGMX-1 undergoes somatic mutation and shows affinity maturation. We have here determined whether somatic mutation occurs in Ig gene rearrangements of the nonpolymorphic human VH6 gene in patients with HIGMX-1. The results demonstrate that somatic hypermutation of Ig gene rearrangements can occur in these patients. Some of the mutations had characteristics suggestive of having been antigen selected. Both the frequency of mutated Ig gene rearrangements and the mutation frequency were lower than that observed in the normal host. The findings provide insight into regulation of the initiation of the mutation process and may explain the high incidence of autoimmune disease in these patients.
Methods
Source of cells. Peripheral blood mononuclear cells were isolated from three patients (HIGMX-1-1, -2, and -3) with the X-linked HyperIgM syndrome. T cells from these patients were activated and evaluated for expression of functional CD40L using soluble CD40, as described (25, 26) . The CD40L gene defect in these patients was characterized by reverse transcriptase-PCR, cloning, and sequencing, as described (26) .
Cloning and sequencing of VH6 transcripts. Total cellular RNA was isolated from -10 x 106 frozen peripheral blood mononuclear cells with TRI Reagent (Molecular Research Center Inc., Cincinnati, OH) according to the manufacturer's specifications. Single-stranded cDNA was prepared from 7-10 isg of the isolated RNA with 200 U Moloney murine leukemia virus reverse transcriptase (GIBCO BRL, Gaithersburg, MD) and 2 ,ug of random hexamer primers (Boehringer Mannheim Biochemicals, Indianapolis, IN). The cDNA was amplified by PCR using the following oligonucleotide primers: VH6-dU-5 'CUACUA-CUACUAGAGGTACAGCTGCAGCAGTCAGGT, a sense primer complementary to the 5' VH6 sequence; Cu-dU-5'CAUCAUCAU-CAUTCTCACAGGAGACGAGGGGGAA, an antisense primer complementary to the 5' region of the human Cp gene segment; and Cy-dU--5'CAUCAUCAUCAUCAGGGGGAAGACC/GGATGGGCCCTT, an antisense primer complementary to the 5' region of the human Cy gene segment. All primers contained deoxyuracil residues to facilitate directional cloning of the amplified product into the plasmid vector pAMP (see below).
The PCR reaction conditions included 200 IM dNTP and 2.5 units of Taq polymerase (Promega Corp., Madison, WI) in a 50-,ul reaction volume. The thermal cycling profile consisted of an initial denaturing step for 2 min at 94°C, and then 35 cycles with an annealing temperature of 55°C for 45 s, elongation at 72°C for 2 min, and denaturation at 94°C for 45 s. This was followed by a final annealing step at 55°C for 2 min and elongation at 72°C for 8 min.
Amplified DNA products were isolated on a 1.2% SeaPlaque low melt agarose gel, and the desired band (-350-400 bp in length) was excised from the gel and directly cloned into the plasmid vector pAMP (GIBCO BRL) by treatment with uracil DNA glycosylase (GIBCO BRL), and transformed into competent XL1-Blue bacteria. Single clones were randomly picked and grown in LB plus ampicillin overnight at 37°C. Plasmid DNA was isolated using the Wizard Miniprep kit (Promega Corp.). VH6 inserts were sequenced bidirectionally by the University of Rochester Core Nucleic Acid laboratory on an Applied Biosystems (Foster City, CA) 370A automated DNA sequencer.
Analysis of single-stranded conformation polymorphism (SSCP). To identify mutated VH6 transcripts, single recombinant clones were selected, grown overnight, and then lysed by boiling for 10 min. 1 ul. of this lysate was amplified with the VH6-dU sense primer above and a VH6 specific antisense primer-5'TGTGTCGGATCCACAGTAATA-CACAGCCGTGTC, complementary to the framework region (FR)3 of VH6, in a 10-,l reaction containing 70 ,uM dNTPs, 0.1 1.l 3,000 Ci/ mmol 32P dCTP (Amersham Corp., Arlington Heights, II), and 1 U of Taq polymerase (Promega Corp.) under the cycling conditions described above. 2 ,ul of the labeled PCR product was diluted 1:50 with 0.1% SDS, 10 mM EDTA, and 2 tl of this was mixed with sequencing stop buffer (United States Biochemicals Corp., Cleveland, OH). Samples were heated at 97°C for 3 min, quenched on ice, and electrophoresed at 10 W constant power through 5% nondenaturing polyacrylamide gels containing 10% glycerol for 16-24 h at room temperature (27) . Gels were dried and exposed to autoradiographs (X-OMAT; Eastman Kodak Co., Rochester, NY) for 24 h at -70°C. Clones that exhibited electrophoresis patterns different from the germline pattern were then sequenced as described above.
Determination of PCR fidelity. A clone containing a previously sequenced germline VH6 sequence was reamplified with sense and antisense dU primers and recloned into pAMP as described above. 10 clones were randomly picked and sequenced bidirectionally to identify any base differences.
Results and Discussion
Peripheral blood lymphocytes of three patients with HIGMX-1 were studied. Activated T cells of all three patients failed to express a functional CD40L as assessed by staining with soluble CD40 (25, 26) . The defects in the CD40L gene in the three patients are shown in Table I . As a result of the mutation, the CD40L mRNA in patient 1 encodes for an altered polypeptide which terminates prematurely (26) . Patient 2 had a single point mutation that alters Gly257 to Ser, and patient 3 had an inframe 6-bp deletion that causes the deletion of Glu142 and Lys143 (Fuleihan, R., N. Ramesh, F. S. Rosen, and R. Geha, unpublished observations).
Somatic mutation of VH6 gene rearrangements was studied because the VH6 gene has been demonstrated to be nonpolymorphic in humans (28, 29) . VH rearrangements to IgM and IgG were analyzed because we, as well as others, have demonstrated mutations universally in IgG (30, 31) and commonly in IgM VH6 rearrangements (32, 33) . Both IgM and IgG-productive VH6 rearrangements were cloned from peripheral blood lymphocytes from all three patients. The frequency of unique VH6 IgG rearrangements was markedly lower than in the normal host, who expressed a diverse VH6 IgG repertoire (30, 31) . Based on analysis of the DJ region of these rearrangements, we isolated only 6 unique VH6 IgG rearrangements from sequencing 17 clones from these patients because of the isolation of multiple duplicate clones. Only one unique VH6 IgG rearrangement was isolated from patient 2, which was mutated (see below), as well as from patient 3 from sequencing four and five clones, respectively, from these patients. In contrast, a single normal individual can express over nine unique VH6 IgG rearrangements and isolation of duplicate clones from normal individuals is much rarer (only 6 duplicates in 23 sequenced clones) (30) . It is unknown whether these IgG VH6 rearrangements arose from B cells that had undergone deletional isotype switching to IgG or arose from B cells with long-processed VH6 transcripts without having undergone deletional switching. EBV-transformed cell lines have been established from patients with HIGMX-1 that express the same V gene with both IgM and IgG isotypes without having undergone deletional switching (34) . In contrast to the VH6 IgG rearrangements, unique VH6 IgM rearrangements were commonly expressed in these patients with no duplicates in 22 clones sequenced randomly from these three patients. Among these 22 IgM and 17 IgG randomly selected clones, there was one 1gM and one IgG clone that was mutated, as detailed below. To more efficiently screen for mutated clones among the IgM rearrangements, we analyzed for SSCP, which is capable of detecting single point mutations. Clones with altered SSCP mobility on nondenaturing gels were then sequenced.
Although the majority of both IgM and IgG VH6 rearrangements were in germline form, there were a total of 7 of 102 (22 randomly selected and 80 screened by SSCP) IgM and 1 of 6 IgG VH6 rearrangements that had somatic mutations in VH6. Patient 1 and patient 2 had 7 of 66 IgM and 1 of 5 IgG VH6 rearrangements that were mutated. None of 36 IgM or the single IgG VH6 rearrangement(s) of patient 3 was mutated. The isolation of germline VH6 IgG sequences contrasts with the finding of mutation in all of the VH6 IgG rearrangements isolated from normal individuals (30, 31 ), and suggests these V genes may arise from B cells that had not undergone deletional isotype switching, as described above. The finding that most HIGMX-1 IgM rearrangements were also in germline form, also contrasts with the VH6 IgM rearrangements of healthy individuals, which are mutated in at least two-thirds of VH6 rearrangements when rearrangements are cloned from RNA of lymphocytes (32, 33) . Mutated V genes expressed with IgM may arise from B cells that have been activated in vivo. When V gene sequences of human surface IgM+ IgD+ and surface IgM+ IgD-B cells are compared, the V genes of the former B cell subset, which probably represent "naive" B cells, are invariably in germline form while those of the latter subset, which may represent previously activated B cells, are usually mutated (35) . Characterization of V genes by use of RNA, as performed here, will skew the results to analysis of V genes of activated B cells because of the higher levels of Ig mRNA in activated than in resting B cells.
The number of mutations per mutated rearrangement ranged from two to nine with a mean of four mutations for the 281 nucleotide bases sequenced between the primers in the VH6 gene, or a mutation frequency (mutations/bp) of 1.4% (Fig.  1 ). The highest frequency was observed in the single-mutated IgG clone (3.2%). This mutation frequency was less than the 3.2% and 5.4% mutation frequency observed in VH6 rearrangements of the IgM and IgG isotype of normal individuals (30) (31) (32) (33) . This frequency, however, was 26-fold greater than the frequency of VH6 background mutations from PCR amplification error, which was quantitated at 5.4 x 10-' errors/bp (1 error per 1,838 bp), representing about 1 error per 6-7 clones of 281 bp. More than one PCR-induced error per clone was not observed.
The distribution and characteristics of the mutations from these clones are shown (Fig. 1) , and tabulated (Table II) . 17 mutations were in the complementarity determining region (CDR) and 15 in the FR. There were 24 replacement and 8 translationally silent mutations, which gave a replacement to silent mutation (R/S) ratio of 3.0. The CDR1 of VH6 was mutated in two rearrangements (HIGMX-1-1-SM, HIGMXI-2-3G) with an R/S ratio of 6:0. Overall, the CDR had an R/S of 3.2 and the FR had a R/S of 2.8. The R/S in CDR1 exceeded the R/S ratio in CDR1 that would be expected based on the germline sequence, as shown (Table II ) (31, 36). In these rearrangements, the R/S for the total CDR was identical to and the R/S in CDR1 exceeded that observed in mutations of VH6 rearrangements of normal individuals (31). The R/S of the mutations in CDR1 (R/S of 6:0) and in CDR2 of the one clone, HIGMX1-1-16M, (R/S of 3:0), are suggestive of their arising by antigenic selection. The findings suggest that a low frequency of somatic mutation occurs in some Ig rearrangements in the absence of normal CD40L-CD40 interactions and germinal center formation in HIGMX-1. Leakiness of the gene defect in these patients does not appear to account for these findings. First, we did not detect expression of CD40L with soluble CD40 on activated PBL of these patients. Second, there was an extreme rarity of unique IgG rearrangements detected, and when detected, they were usually in germline form. This finding suggests that these rearrangements may have been derived from B cells that had not undergone deletional isotype switching. Mutated clones were usually of the IgM isotype, representing over 10% of the IgM rearrangements in patients 1 and 2. Mutation is, therefore, occurring in the absence of leakiness for isotype switching, a process that requires CD40L-CD40 signaling. It has been shown recently that expression of the wild-type CD40L, by only a small population of T cells in carriers of HIGMX-1, is sufficient to maintain normal isotype switching to IgG and antibody responses (37) . Both the frequency of VH6 rearrangements with mutation and the mutation frequency when it occurred was lower, however, than in the normal host. In part, the mutation frequency could be lower in HIGMX-1 than in normal individuals because of the failure to generate long-term memory B cells in this syndrome (19, 20) . Milstein and colleagues suggest that the somatic mutation process can recur multiple times in memory B cells (38) and, thus, could add to the frequency of mutations observed in V genes in normal individuals.
It has been debated whether somatic mutation initiates only in germinal centers or begins outside follicles before germinal center formation with activated B cells with a low frequency of mutation then migrating to form germinal centers and undergoing increased mutation (8, 11) . The somatic mutations observed in the V genes of these patients are possibly induced in Somatic Mutation in X-Linked HyperlgM Syndrome 1391 A. 10 15 7R1   20  25  30  CDR1 35  FR2  J04097   CCA OOA CTO OTG AOG CCC TCG CAO ACC CTC TCA CTC ACC TGT OCC ATC TCC G00 OAC AOT GTC TCT AGC ARC AOT OCT OCT TOO AAC TOO ATC AGG CAG  XIaGml- 40  50  55 CDR2  60  65  FR3  70  J04097 TCC CCA TCG AGA GGC CTT GAG TGG CTG GGA AGG ACA TAC TAC AGG TCC AAG TGG TAT AALT GAT TAT GCA GTA TCT GTG AAA AGT CQA ATA ACC ATC AAC
CCA GAC ACA TCC ARG AAC CAG TTC TCC CTG CAG CTG ARC TCT GTG ACT CCC GAG QAC ACG GCT GTG TAT TAC TTGCA AGA GA extrafollicular locations through a CD40-independent pathway that induces a low level of somatic mutation. Based on recent studies of in vivo injection of mice with a soluble CD40 fusion protein, Gray and colleagues have suggested that there exists a TD, CD40L-independent pathway that leads to IgM antibody responses (39) . Such a pathway could explain IgM antibody responses to TD antigens in the X-linked HyperIgM syndrome (19, 20) and to some TD antigens in CD40 and CD40L gene knockout mice (12, 14) . Although memory B cells are not generated in the absence of normal CD40L function (12-14, 20, 39, 40) , this CD40L independent pathway may represent a minor pathway in the normal host that is capable of activating proliferation of surface IgM expressing B cells. In the presence of normal CD40L function, these activated cells would immediately traffic to germinal centers and undergo more extensive mutation and would, therefore, not be detected. The results here suggest this pathway is capable of initiating somatic mutation. The relatively lower frequency of mutation compared to VH6 rearrangement of normal individuals suggests that a germinal center environment is required for a high rate of mutation. Generation of mutated antibodies in the absence of germinal center formation in patients with HIGMX-1 may not allow deletion of B cells that express self-reactive antibodies (41). The ability to generate mutated immunoglobulins in the absence of germinal center formation may promote the development of autoantibodies and could explain the high frequency of autoimmune disease that occurs in patients with HIGMX-1 (19).
